1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Dermatology Drugs Market 

4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User

4.2. Industry Outlook

4.3. Skin infections patients by age

4.4. PESTLE Analysis

4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition

4.6. Market Dynamics and Trends
4.6.1. Growth Drivers
4.6.2. Restraints
4.6.3. Challenges
4.6.4. Key Trends

4.7. Covid-19 Impact Assessment on Market Growth Trend

4.8. Market Growth and Outlook
4.8.1. Market Revenue Estimates and Forecast (US$ Bn), 2019 – 2032
4.8.2. Market Volume Estimates and Forecast (MT), 2019 – 2032
4.8.3. Price Trend Analysis, By Drug Type

4.9. Competition Dashboard
4.9.1. Market Concentration Rate
4.9.2. Company Market Share Analysis (Value %), 2023
4.9.3. Competitor Mapping

5.1. Key Insights

5.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
5.2.1. Branded Prescription Drugs
5.2.2. Generic Prescription Drugs
5.2.3. Over-The Counter Drugs (OTC)

6.1. Key Insights

6.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
6.2.1. Ointments 
6.2.2. Cream
6.2.3. Lotion 
6.2.4. Gel 
6.2.5. Tablets
6.2.6. Other Formulations

7.1. Key Insights

7.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
7.2.1. Oral Medicine 
7.2.2. Topical Medicine 
7.2.3. Parenteral Medicine

8.1. Key Insights

8.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
8.2.1. Acne
8.2.2. Dermatitis
8.2.3. Psoriasis
8.2.4. Rosacea
8.2.5. Inflammatory dermatoses
8.2.6. Others

9.1. Key Insights

9.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
9.2.1. Retail Channel
9.2.2. Non-retail
9.2.3. Online Channel

10.1. Key Insights

10.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Western Europe
10.2.2.1.1. The UK
10.2.2.1.2. Germany
10.2.2.1.3. France
10.2.2.1.4. Rest of Western Europe
10.2.2.2. Eastern Europe
10.2.2.2.1. Italy
10.2.2.2.2. Spain
10.2.2.2.3. Poland 
10.2.2.2.4. Russia
10.2.2.2.5. Rest of Eastern Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. South Korea
10.2.3.5. Australia & New Zealand
10.2.3.6. ASEAN
10.2.3.6.1. Thailand 
10.2.3.6.2. Singapore 
10.2.3.6.3. Vietnam 
10.2.3.6.4. Indonesia
10.2.3.6.5. Malaysia 
10.2.3.6.6. Philippines
10.2.3.6.7. Cambodia 
10.2.3.6.8. Rest of ASEAN
10.2.3.7. Rest of Asia Pacific
10.2.4. Rest of The World
10.2.4.1. Middle East & Africa
10.2.4.1.1. UAE
10.2.4.1.2. Saudi Arabia
10.2.4.1.3. South Africa
10.2.4.1.4. Rest of MEA
10.2.4.2. South America
10.2.4.2.1. Argentina
10.2.4.2.2. Brazil
10.2.4.2.3. Rest of South America

11.1. Key Insights

11.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
11.2.1. By Drug Type
11.2.2. By Formulation 
11.2.3. By Route of Administration
11.2.4. By Therapeutic Application 
11.2.5. By Distribution Channel
11.2.6. By Country 

12.1. Key Insights

12.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
12.2.1. By Drug Type
12.2.2. By Formulation 
12.2.3. By Route of Administration
12.2.4. By Therapeutic Application 
12.2.5. By Distribution Channel 
12.2.6. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
13.2.1. By Drug Type
13.2.2. By Formulation 
13.2.3. By Route of Administration
13.2.4. By Therapeutic Application 
13.2.5. By Distribution Channel 
13.2.6. By Country

14.1. Key Insights

14.2. Market Size and Forecast, 2019 – 2032 (US$ Mn and MT)
14.2.1. By Drug Type
14.2.2. By Formulation 
14.2.3. By Route of Administration
14.2.4. By Therapeutic Application 
14.2.5. By Distribution Channel
14.2.6. By Country

15.1. Amgen Inc
15.2. Bausch Health Companies Inc.
15.3. Botanix Pharmaceuticals
15.4. Bristol-Myers Squibb Company
15.5. Eli Lilly and Company
15.6. Johnson & Johnson
15.7. LEO Pharma A/S
15.8. Merck KGaA
15.9. Mylan N.V.
15.10. Novartis AG
15.11. Pfizer Inc.
15.12. Other Prominent Players